Global Hair Growth Supplement And Treatment market size is expected to reach $14.25 billion by 2029 at 9.7%, segmented as supplements, oral tablets, soft gels, powder supplements, liquid supplements
Read More
Global Graft Versus Host Disease (GVHD) Treatment market size is expected to reach $4.1 billion by 2029 at 7.5%, segmented as by corticosteroids, prednisolone, methylprednisolone, dexamethasone, hydrocortisone, betamethasone, budesonide
Read More
Global Gouty Arthritis market size is expected to reach $4.9 billion by 2029 at 7.2%, segmented as by acute gouty arthritis, monosodium urate crystals-induced acute gout, acute gout attack (intermittent flares)
Read More
Global Gonadotropin-Releasing Hormone (GnRH) Agonist market size is expected to reach $4.72 billion by 2029 at 2.8%, segmented as by leuprorelin, injectable leuprorelin, implantable leuprorelin
Read More
Global Giant-Cell Arteritis market size is expected to reach $1.36 billion by 2029 at 5%, segmented as by prednisone, oral prednisone, intravenous (iv) prednisone, low-dose prednisone therapy, high-dose prednisone therapy
Read More
Global Geriatric Care Services market size is expected to reach $1519.57 billion by 2029 at 7.1%, segmented as by homecare, personal care services ( bathing, dressing), companionship services, home health aide services, nursing care services at home
Read More
Global Genomics Services market size is expected to reach $35.41 billion by 2029 at 17.9%, segmented as by product, instruments or systems or software, consumables and reagents
Read More
Global Genomic Data Analysis And Interpretation market size is expected to reach $2.42 billion by 2029 at 13.3%, segmented as by software, data analysis software, genome sequencing software, bioinformatics software, variant analysis software
Read More
Global Genital Warts market size is expected to reach $2.57 billion by 2029 at 5.4%, segmented as by imiquimod, imiquimod cream 5%, imiquimod cream 3.75%
Read More
Global Genital Herpes market size is expected to reach $3.05 billion by 2029 at 6.8%, segmented as by diagnosis, polymerase chain reaction (pcr) tests, viral culture tests, blood antibody tests (serology), antigen detection tests
Read More